Effects of Osteopathic Technique on Autonomic Nervous System Activity
Launched by SOMATICMED · Aug 14, 2024
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how certain osteopathic techniques, specifically the cranial osteopathic manipulation technique known as CV4 and rib raising (RR), affect the autonomic nervous system (ANS) activity in healthy individuals. The ANS controls automatic functions in our body, like heart rate, and this study aims to see if these techniques can improve how well the ANS works. About 109 healthy adults between the ages of 20 and 60 years are being recruited for this research.
To participate, individuals should not be undergoing any rehabilitation or physiotherapy and must not have certain health issues, such as unstable heart rhythms, pregnancy, or recent surgeries related to the head. Participants can expect to receive the osteopathic treatments and their heart rate variability (a measure of ANS activity) will be monitored. This study is important because it could help us understand better ways to manage conditions related to the autonomic nervous system.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age between 20 and 60 years.
- • Subjects not currently undergoing any form of rehabilitation, physiotherapy, or osteopathy
- Exclusion Criteria:
- • Unstable arrhythmia in the patient's history and symptoms related to chest organs (retrosternal pain, difficulty breathing).
- • Pregnancy.
- • Menstruation.
- • Smoking.
- • Symptoms suggestive of disorders related to bowel obstruction (bloating with pain, vomiting, diarrhea).
- • Surgical treatment in the head.
- • Neurological diseases.
- • Back and peripheral joint pain, trauma, and musculoskeletal dysfunction in the last 12 months.
- • Having undergone physiotherapy or osteopathy treatment within the last month, regardless of the reason
About Somaticmed
SomaticMed is a pioneering clinical trial sponsor dedicated to advancing innovative therapeutic solutions in precision medicine. Focused on harnessing cutting-edge research and technology, SomaticMed aims to enhance patient outcomes by facilitating the development of targeted treatments across various disease areas. With a commitment to rigorous scientific methodology and regulatory compliance, the organization collaborates with leading researchers and healthcare professionals to drive clinical studies that prioritize patient safety and efficacy. Through its strategic initiatives, SomaticMed is positioned to contribute significantly to the future of personalized healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Wołomin, Prądzyńskiego, Poland
Wołomin, , Poland
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported